Mrs
Yael
Shalem Givon

Legal Director

London Office

Law

Telephone. +44(0) 207 776 5100
Email. [email protected]

Experience

Yael is an experienced IP litigator and specialises in contentious IP work, advising clients on IP enforcement and infringement matters. Over the last 10 years, Yael has worked in Israel and in the UK and has gained substantive experience in the healthcare sector. Yael held both in-house and private practice positions, lead and managed multi-jurisdictional litigation proceedings and other enforcement actions.

Yael completed BSc in Biology and LLB in Law, both from the Hebrew university in Jerusalem, and is a member of the Israeli Bar Association and a Registered Foreign Lawyer in the UK. Yael's experience expands across all areas of IP, including disputes concerning patents, trade marks and design rights.

Qualifications

Solicitor

Israel


BSC

Life Sciences, Biology, Hebrew University, Jerusalem

LLB

Law, Hebrew University, Jerusalem

POSTGRADUATE DIPLOMA OR CERTIFICATE

Registered Foreign Lawyer

Publications

A new dawn for SPCs

View publication online

Conferences: 2022

March 29th 2022

IPBC Europe 2022

Attended

Event details

March 1st 2022

HGF Retail Webinars: Upcycling, recycling and resale

Speaker

Event details

Conferences: 2021

September 22nd 2021

Luxury Law Summit Europe 2021

Speaker

Event details

March 2nd 2021

Child Health Technology Conference 2021

Attended

Event details

January 14th 2021

HGF IP in Healthcare Virtual Conference 2021

Speaker

Event details

Related News

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

3D shape trade marks for medical devices

Innovation in medical devices continues strongly and the introduction of IoT and 3D printing (amongst others) has led to an acceleration in new medical devices. Whilst patents and designs are …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

“For medical purposes” – a case for unblurring the lines between pharma and nutritional products

Food-pharma industry convergence is not a new development. In 2013, a study of the patent citation data of 274 published European patents by 5 EU Medical Nutrition companies revealed the …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article
Event - 30th April 2022

INTA 2022 Annual Meeting Live+

The HGF European team will be attending the INTA 2022 Annual Meeting Live+. It is being held on 30th April – 4th May in Washington, D.C. INTA brings together the …

Event details

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.